Compare MRVI & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | PD |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.0M | 532.7M |
| IPO Year | 2020 | 2019 |
| Metric | MRVI | PD |
|---|---|---|
| Price | $4.82 | $9.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $4.13 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 2.6M | 1.6M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 416.95 |
| EPS | N/A | ★ 0.13 |
| Revenue | $185,743,000.00 | ★ $492,546,000.00 |
| Revenue This Year | $12.54 | $3.58 |
| Revenue Next Year | $7.87 | $2.88 |
| P/E Ratio | ★ N/A | $3.99 |
| Revenue Growth | N/A | ★ 5.36 |
| 52 Week Low | $1.99 | $5.70 |
| 52 Week High | $5.00 | $17.45 |
| Indicator | MRVI | PD |
|---|---|---|
| Relative Strength Index (RSI) | 68.22 | 80.83 |
| Support Level | $3.27 | $6.08 |
| Resistance Level | $5.00 | $16.61 |
| Average True Range (ATR) | 0.25 | 0.44 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 81.91 | 98.04 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.